| Literature DB >> 30884832 |
Agnieszka Haryńska1, Justyna Kucinska-Lipka2, Agnieszka Sulowska3, Iga Gubanska4, Marcin Kostrzewa5, Helena Janik6.
Abstract
The widespread use of three-dimensional (3D) printing technologies in medicine has contributed to the increased demand for 3D printing materials. In addition, new printing materials that are appearing in the industry do not provide a detailed material characterization. In this paper, we present the synthesis and characterization of class="Chemical">polycaprolactone (Entities:
Keywords: 3D printing; PCL based TPU; fused deposition modeling; fused-filament fabrication; material characterization; polyurethane filament
Year: 2019 PMID: 30884832 PMCID: PMC6471510 DOI: 10.3390/ma12060887
Source DB: PubMed Journal: Materials (Basel) ISSN: 1996-1944 Impact factor: 3.623
Review of medical-grade polyurethane systems in which polycaprolactone (PCL) is used as a polyol part of the chain.
| Polyurethane System | Short Description | Year | Reference |
|---|---|---|---|
| (SF/LDI/PCLdiol/BDA) | Tissue scaffolds with the structure of nanofibers for the regeneration of the heart valves obtained via electrospinning. | 2018 | [ |
| (HDI/PCLtriol/PEG/glycerol) | Biodegradable polyurethane films with cross-linked hydrolysable bonds and a homogeneous structure for biomedical applications. PU with hydrogel behavior and susceptibility to hydrolytic degradation. | 2015 | [ |
| (LDI-ε-caprolactone)block/LDI) | Biodegradable PU with potential application in soft tissue engineering. A synthesis of a poly (L-lactide-ε-caprolactone) block copolymer was carried out, which was then used to react with L-lysine diisocyanate(LDI). The PU obtained can be used as a viscous injection which is cured in situ. | 2017 | [ |
| (BDI/PCLdiol/L-Lysine ethyl ester dihydrochloride) | Poly(ester-urethane) tissue scaffolds were obtained using the melt-extrusion additive manufacturing technique. The obtained scaffolds were cytocompatible and tested for use in the regeneration of myocardial tissue. | 2014 | [ |
| (HDI/PCLdiol/BDO/Fe2O3 nanoparticles) | A poly(ester-urethane) material of potential application for the regeneration of nerve tissue was obtained. The addition of nanoparticles improved the electrical conductivity, hydrophilicity and roughness of the obtained material. Biological tests show that nanocomposite was biocompatible and has suitable cell viability (in vitro cytotoxicity). | 2014 | [ |
| (HDI/PCLdiol/PEG) | Electrospunednanofiberpoly(ester-urethane) membranes dedicated for guided bone regeneration. Obtained membranes had mechanical properties slightly higher than commercially available collagen or PTFE membrane. | 2018 | [ |
Description of raw materials used in polyurethane synthesis.
| Compound | Supplier | Short Description | Structure Formula |
|---|---|---|---|
| PCL diol | Perstrop, | Linear polyestrodiol, terminated with hydroxyl groups; Appearance: white, waxy solid; Average molecular weight: 2000 g/mol; Melting temp: 40–50 °C; |
|
| HDI | Sigma- | Aliphatic diisocyanate; Appearance: colorless liquid; |
|
| BDO | Brenntag, | Low molecular weight chain extender Molar mass = |
|
Figure 1FTIR spectra of synthesized S-TPU(PCL)0.9/1.1.
Description of vibrations in FTIR spectra of S-TPU(PCL)0.9/1.1.
| Wavelength [cm−1] | Band | Description |
|---|---|---|
| 3330–3318w | N-H stretching of urethane bond. Free and hydrogen bonded NH. | |
| 2917w, 2850w | Asymmetric and symmetric stretching C-H vibrations occurring in the aliphatic chains. | |
| 1717s | Stretching vibration of carbonyl group of PCL part. | |
| 1686vs, 1660w | Stretching vibration of carbonyl group occurring in the urethane bond; non-hydrogen bonded and strongly hydrogen bonded urethane group. | |
| 1542m | N-H deformation of urethane bond (bending vibration). | |
| 1464m | C-H deformation (scissoring in plane). | |
| 1223s | Stretching vibration (urethane bonding). | |
| 1160s | Stretching vibration of ester (PCL part). | |
| 1065m, 1038m | Stretching vibration of C-O occurring in the urethane bond. | |
| 730v | γC–C | Skeletal vibrations of alkaline carbon chain (-C-Cn-, n>4) present in HDI/ or PCL structure. |
| 640m | Wide spectrum of N-H wagging, out of plane. |
vw—very weak, w—weak, m—medium, s—strong, vs—very strong, v—variable.
Figure 2Raman spectroscopy of synthesized S-TPU(PCL)0.9/1.1.
Figure 3Differential scanning calorimetry (DSC) curves of S-TPU(PCL)0.9/1.1 with designated values; (a) first heating run, (b) first cooling run.
Figure 4TGA graph of S-TPU(PCL)0.9/1.1 with a derivative curve (DTG).
Thermogravimetric analysis (TGA) and DTG results for obtained polyurethanes.
| Sample | TSa (°C) | Tmaxb(°C) | T5%c(°C) | T30% d(°C) | T50% e(°C) | Toffsetf(°C) | |
|---|---|---|---|---|---|---|---|
| I | II | ||||||
| S-TPU(PCL)0.9 | ~260 | 351 | 430.6 | 283.8 | 330.3 | 344.8 | 455 |
| S-TPU(PCL)1.1 | ~275 | 393.7 | 445 | 307.5 | 358.6 | 381.5 | 493 |
a Thermal stability (up to 1% mass loss temperature), b First I/second II stage maximum rate of degradation temperature, c,d,e5,30,50% mass loss temperature, f complete degradation temperature.
Hardness, density, and tensile properties of synthesized materials.
| Material Properties | S-TPU(PCL)0.9 | S-TPU(PCL)1.1 | |
|---|---|---|---|
| Shore Hardness [°Sh] | A | 84.36 ± 1.12 | 91.05 ± 4.86 |
| D | 30.30 ± 1.27 | 36.97 ± 6.21 | |
| Density [g/cm3] | 1.118 ± 0.007 | 1.021 ± 0.029 | |
| TSB [MPa] | 8.55 ± 0.49 | 21.40 ± 3.26 | |
| εb[%] | 204.85 ± 13.74 | 726.32 ± 58.55 |
HS—theoretical content of hard segments.
Contact angle measurements of S-TPU(PCL)0.9/1.1 with respect to various liquids.
| Sample | Contact Angle Measurements | |||
|---|---|---|---|---|
| Diiodomethane | Formamide | Water | Ethylene Glycol | |
| [°] | [°] | [°] | [°] | |
| S-TPU(PCL)0.9 | 63.22 ± 1.08 | 88.91 ± 2.08 | 104.43 ± 2.07 | 81.62 ± 0.82 |
|
|
|
|
| |
| S-TPU(PCL)1.1 | 59.86 ± 1.28 | 90.10 ± 1.99 | 107.86 ± 0.88 | 83.15 ± 2.73 |
|
|
|
|
| |
Surface energy of S-TPU(PCL)0.9/1.1 calculated using the Owens–Wendt and acid-base method.
| Sample | Owens-Wendt Method | Acid-Base Method | ||||||
|---|---|---|---|---|---|---|---|---|
| Total | Diperse Part | Polar Part | Total | L-W Part | Acid-Base Part | Acid Part | Base Part | |
| mN/m | mN/m | mN/m | mN/m | mN/m | mN/m | mN/m | mN/m | |
| S-TPU(PCL)0.9 | 25.87 | 25.87 | 0.00 | 28.69 | 28.14 | 0.55 | 0.24 | 0.31 |
| S-TPU(PCL)1.1 | 23.52 | 23.30 | 0.21 | 27.68 | 26.46 | 1.21 | 0.27 | 1.35 |
Figure 5Graph of percentage water absorption change over time of S-TPU(PCL)0.9/1.1 samples.
Mass change of S-TPU(PCL) samples 0.9/1.1 during incubation in PBS at 37 °C.
| Sample | Time of Incubation [Weeks] | ||
|---|---|---|---|
| 1 | 4 | 12 | |
| Mass Change [%] | |||
| S-TPU(PCL)0.9 | 99.575 ± 0.062 | 99.887 ± 0.080 | 100.168 ± 0.069 |
| S-TPU(PCL)1.1 | 99.972± 0.039 | 99.973 ± 0.039 | 100.182 ± 0.075 |
Figure 6Results of study on short-term degradation in 2M HCl and 5M NaOH of S-TPU(PCL)0.9/1.1, (a) optical microscopy, (b) graph of percentage mass loss during degradation process, (c,d) FTIR spectrum measured at different time of degradation of S-TPU(PCL)0.9.
Figure 7The effect of S-TPU(PCL)0.9/1.1 extracts on the growth of C2C12 cells tested via MTT assay after 24, 48, and 72 h of incubation.
Melt-extrusion parameters of F-TPU(PCL)0.9 * filament formation.
| Process | T1 [°C] | T2 [°C] | Rotation Speed [rpm] | Dose Rate (g/min) | Filament Appearance |
|---|---|---|---|---|---|
| 1 | 165 | 175 | 40 | 50 |
|
| 2 | 185 | 200 | 80 | 50 |
|
| 3 | 185 | 190 | 80 | 50 |
|
| 4 | 175 | 185 | 50 | 30 |
|
* For the filament formation stage the S-TPU(PCL)0.9 was selected due to, cytotoxicity results, higher swelling ratio, as well as lower water contact angle than S-TPU(PCL)1.1 sample.